Stimwave Technologies, the leading innovator of wireless medical pain relief implant bioelectric technology, has announced that Professional Football Hall of Famer Joe Montana has signed as their official spokesperson.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190711005223/en/
Joe Montana Getty Images
“With a decorated football career culminating with his Hall of Fame induction in 2000, nobody knows better about living with chronic pain than Joe Montana,” said Laura Perryman, Founder and CEO of Stimwave. “We are honored to bring Joe to the Stimwave family and thrilled that this legendary athlete will raise awareness and encourage others to discover our breakthrough technology to relieve chronic pain.”
Hall of Famer and four time Super Bowl champion continues to feel the physical effects of his playing career that ended in 1994.
“After years of dealing with the residual effects of my professional football career, I am excited to have found this battery-free, minimally-invasive alternative to opioids that relieves chronic pain and I’m eager to help other chronic pain sufferers receive this life changing micro-implant,” said Montana.
Montana has undergone multiple knee surgeries as well as back, neck and shoulder surgery. He also suffers from arthritis in his elbows, knees and hands.
Stimwave offers the world’s only wireless, battery-free, opioid-free implant cleared by the FDA to treat chronic neuropathic pain throughout the body, from back and leg pain addressed by spinal cord stimulation (SCS) to peripheral nerve stimulation (PNS) that treats pain at the source. Including shoulder pain, wrist pain, elbow pain, knee pain, hip pain and more; allowing more patients to be treated than ever before with a viable, affordable alternative to help fight opioid usage across the country.
Representing a life-changing technological breakthrough for the more than 400 million people worldwide who endure daily chronic pain, the Stimwave Freedom Stimulators are also the smallest neuromodulation devices available, at a volume size of 0.4 cc compared to the next smallest form factor at 15 cc and greater – Stimwave’s implants are 35x-100x smaller than any conventional system.
Stimwave Technologies Incorporated is a privately held medical device company engaged in the development, manufacture, and commercialization of wirelessly powered, injectable, microtechnology neurostimulators, providing patients with a convenient, safe, minimally invasive, and highly cost-effective pain management solution that is easily incorporated into their daily lives. Stimwave’s goal is to evolve its patented, cutting-edge platform into the default for neuromodulation, increasing the accessibility for patients worldwide while lowering the economic burden of pain management. www.stimwave.com